I have a diverse background—as a financial journalist, resident physician, mixed martial artist, painter, entrepreneur, chemistry instructor and web developer—that enabled me to pioneer the “Integrated Investing Research” approach.
I provide consulting to clients, both the retail and professional investors. I accurately forecasted many clinical trials, such as the Flint Trials for Intercept, the Ascend Trials for InterMune and the Affinity Trials MannKind, just to name a few. Through Vincata Enterprises, LLC, I helped many clients to unlock substantial values for their investments.
As an expert in biopharmaceutical analysis, I am also more than capable of analyzing any other industries. Though not shown on Seeking Alpha, I have picked an aggregate basket of outperforming stocks.
Investing in biotech is highly risky, but it can be quite rewarding when investors have an edge in data analysis. Physicians who are rigidly scientific tend to lack the analytical prowess of financial experts. Conversely, financiers usually do not possess a physician’s medical expertise. Likewise, scientists are skillful in data analysis; yet they might not be familiar with a physician’s prescribing patterns, which is a requisite to successful biotech investing.
You can visit my website at https://www.retailinvestor360.com for business inquiry.
Retired career stockbroker, author, national speaker/educator, investment newsletter editor and art collector. Strong interest in emerging growth stocks, emerging markets with a special focus on VietNam and GARP with dividends. VietNam war veteran who lives 50/50 between VietNam and USA.
Have been an investor for 60 years. Last 20 years have concentrated on biotechs. Have been senior exec with Shell and ITT before retiring 30+ years ago. My working areas were finance, informatics and international management. Taught MBA courses in management, informatics and communications. Speak French and Spanish plus some German.
Technical Analyst, Publishing Ideas at www.tradingview.com, Sep 2011-present
VP Equity Trading, Technical Analyst, Registered Options Principle, S.G. Warburg & Co. Inc., 1990-1994
Portfolio Manager, 1994-present.
Trading System Developer, Trader, Manager, 2006-2009, Futures Trading Systems.
Day-Trader in Listed Equities, 1997-2003.
Publisher and Market Commentator, Developer and Advisor: www.tradingview.com
Publish forecasts and make market timing decisions using both fundamental and technical data.